Cohance Lifesciences Appoints Former Cipla CEO Umang Vohra to Spearhead Growth Efforts, Stock Surges 20%

Cohance Lifesciences Appoints Umang Vohra as Executive Chairman and Group CEO

Cohance Lifesciences Ltd, an Indian Contract Development and Manufacturing Organization (CDMO) platform backed by private equity firm Advent, has announced the appointment of pharmaceutical industry veteran Umang Vohra as its new Executive Chairman and Group CEO. This strategic move marks a high-stakes leadership transition as the company seeks to overcome stagnant growth and regulatory hurdles.

The stock market has reacted positively to the appointment, with shares of Cohance rising 19.99 percent to Rs 432.10 on the National Stock Exchange (NSE) at 9:49 am.

Umang Vohra, who spent a decade transforming Cipla into a diversified global player, will take over as Executive Chairman on May 1 and assume the Group CEO role on May 20. He succeeds Vivek Sharma, who is stepping down for personal reasons after overseeing the integration of the business into a science-led platform.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Cohance, majority-owned by private equity firm Advent International, has built a sophisticated R&D engine with over 400 scientists. However, the company (formerly Suven Pharmaceuticals) has recently struggled with operational headwinds, including a slowdown in its agrochemical business and "inventory normalization" issues that have weighed on its top line. The market's reaction to Cohance's recent performance has been lukewarm, with the stock trading significantly below its 52-week highs as investors look for a clear path to commercializing its R&D pipeline.

Vohra brings a wealth of experience to the role, and his appointment is designed to drive growth and stability at Cohance. To ensure a smooth transition, Vivek Sharma will remain with the company as an Advisor for the next nine months, providing continuity and reassurance to shareholders.

Note: The table above presents a comparison of the companies mentioned in the article. However, due to the lack of specific data in the original text, the table is currently empty.

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline